Ekaterina Kabin

Ekaterina Kabin

Auto-generated profile, based on publicly available information

Ekaterina Kabin

Department of Physiology, Johns Hopkins Medical Institutes, Baltimore, Maryland, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
EKEkaterina Kabin
Ekaterina Kabin
YDYixuan Dong
Yixuan Dong
SRShubhrajit Roy
Shubhrajit Roy
JSJulia Smirnova
Julia Smirnova
JSJoshua Smith
Joshua Smith
SLSvetlana Lutsenko
Svetlana Lutsenko
α-lipoic acid (LA) is an essential cofactor for mitochondrial dehydrogenases and is required for cell growth, metabolic fuel production, and antioxidant defense. In vitro, LA binds copper (Cu) with high affinity and as an endogenous membrane permeable metabolite could be advantageous in mitigating the consequences of Cu overload in human diseases. We tested this hypothesis in 3T3-L1 preadipocytes with inactivated Cu transporter Atp7a; these cells accumulate Cu and show morphologic changes and mitochondria impairment. Treatment with LA corrected the morphology ofAtp7a−/−cells similar to the Cu chelator bathocuproinedisulfonate (BCS) and improved mitochondria function; however, the mechanisms of LA and BCS action were different. Unlike BCS, LA did not decrease intracellular Cu but instead increased selenium levels that were low inAtp7a−/−cells. Proteome analysis confirmed distinct cell responses to these compounds and identified upregulation of selenoproteins as the major effect of LA on preadipocytes. Upregulation of selenoproteins was associated with an improved GSH:GSSG ratio in cellular compartments, which was lowered by elevated Cu, and reversal of protein oxidation. Thus, LA diminishes toxic effects of elevated Cu by improving cellular redox environment. We also show that selenium levels are decreased in tissues of a Wilson disease animal model, especially in the liver, making LA an attractive candidate for supplemental treatment of this disease.

1 January 2025 in Human Mutation
Verified
Journal Article
Open access
JCJenifer Calvo
Jenifer Calvo
THTomáš Heger
Tomáš Heger
EKEkaterina Kabin
Ekaterina Kabin
WMWilliam R. Mowrey
William R. Mowrey
GAGuillermo Del Angel
Guillermo Del Angel
SLSvetlana Lutsenko
Svetlana Lutsenko
Wilson disease is a disorder of copper (Cu) homeostasis caused by the malfunction of Cu transporter ATP7B and associated Cu accumulation in tissues. The existence of over 700 disease‐associated variants in the ATP7B gene and a broad spectrum of disease manifestations complicate the analysis of genotype–phenotype correlations and the development of better treatments for this disorder. To assist such studies, we screen 101 variants of ATP7B for expression and Cu transport activity in human fibroblasts lacking active ATP‐dependent Cu transporters. The ClinVar database classified 59 of these as variants of uncertain significance or having conflicting pathogenicity classifications; six variants were not in the database. Thirty‐three of the variants have been previously characterized by other assays. Only three variants (S657R, G1061E, and G1266R) resulted in the complete inactivation of Cu transport. The in silico analysis of these mutants was used to rationalize this drastic effect on ATP7B activity. The remaining ATP7B variants showed a range of Cu transport activities. Coexpression of variants with different properties yielded activity values different from the simple average. The advantages and limitations of this functional screen are discussed.

30 March 2018 in FEBS Open Bio
Verified
Journal Article
Open access
PDF file
JSJulia Smirnova
Julia Smirnova
EKEkaterina Kabin
Ekaterina Kabin
VTVello Tougu
Vello Tougu
PPPeep Palumaa
Peep Palumaa
Zinc finger (ZF) protein motifs, stabilized by binding of Zn(II), typically function as interaction modules that bind nucleic acids, proteins and other molecules. The elucidation of the redox states of ZF proteins in cellular conditions, which depend on their midpoint redox potentials, is important for understanding of ZF functioning. In the present study we determined the midpoint redox potentials for representatives of Cys2His2 and Cys4 types of ZF proteins in apo and Zn(II)‐bound forms using electrospray ionization mass spectrometry. The midpoint redox potentials of the apo forms of Cys2His2 and Cys4 ZF proteins were −326 and −365 mV (pH 7.5), respectively. These values are close to the cytosolic redox potential of approx. −350 mV (pH 7.5) and thus we can conclude that the apo form of Cys2His2‐type ZF proteins is predominantly reduced but apo forms of Cys4‐type ZF proteins should be substantially oxidized in the cytoplasm. As expected, Zn(II) binding stabilized the reduced forms of both ZF proteins: the corresponding redox potential values were −284 and −301 mV, respectively. Consequently, binding of Zn(II) ions to ZF motifs can act as a sensitive switch that activates the functioning of the ZF motifs within the cell, and also protects them from oxidation and can function as part of a redox‐sensitive regulation mechanism of cellular functions.